Nontraditional atherosclerotic risk factors and extent of coronary atherosclerosis in patients with combined impaired fasting glucose and impaired glucose tolerance.

There are many clinical trials attempting to find that one drug that, when given at high dosages, can reverse or stop plaquing of the arteries. Of course, all this money spent is in the face of lifestyle changes and natural compounds that already to what the drug companies are trying to mimic.

This study found a relationship between the amount of plaquing in the coronary arteries and several “non-traditional” risk factors. So often physicians view coronary heart disease risk with blinders on — check cholesterol, blood pressure, family history, etc… But these risk factors only show a small part of what’s going on as far as risk of CHD in the patient.

This study found that insulin resistance was a major contributor to plaquing. No big surprise, of course, given how pro-inflammatory insulin resistance is.

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.